These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36557069)

  • 21. Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations.
    Deniger DC; Yu J; Huls MH; Figliola MJ; Mi T; Maiti SN; Widhopf GF; Hurton LV; Thokala R; Singh H; Olivares S; Champlin RE; Wierda WG; Kipps TJ; Cooper LJ
    PLoS One; 2015; 10(6):e0128151. PubMed ID: 26030772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The onco-embryonic antigen ROR1 is expressed by a variety of human cancers.
    Zhang S; Chen L; Wang-Rodriguez J; Zhang L; Cui B; Frankel W; Wu R; Kipps TJ
    Am J Pathol; 2012 Dec; 181(6):1903-10. PubMed ID: 23041612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Value of the Expression of Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) in Chronic Lymphocytic Leukemia.
    Yikilmaz AŞ; Bakanay ŞM; Avcı DN; Akinci S; Falay M; Özet G; Dilek İ
    Int J Hematol Oncol Stem Cell Res; 2023 Jan; 17(1):39-47. PubMed ID: 37638287
    [No Abstract]   [Full Text] [Related]  

  • 24. ROR1 is highly expressed in circulating tumor cells and promotes invasion of pancreatic cancer.
    Xu GL; Shen J; Xu YH; Wang WS; Ni CF
    Mol Med Rep; 2018 Dec; 18(6):5087-5094. PubMed ID: 30272313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional and clinical significance of ROR1 in lung adenocarcinoma.
    Schiavone G; Epistolio S; Martin V; Molinari F; Barizzi J; Mazzucchelli L; Frattini M; Wannesson L
    BMC Cancer; 2020 Nov; 20(1):1085. PubMed ID: 33172431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Destabilization of ROR1 enhances activity of Ibrutinib against chronic lymphocytic leukemia in vivo.
    Liu Z; Liu J; Zhang T; Shi M; Chen X; Chen Y; Yu J
    Pharmacol Res; 2020 Jan; 151():104512. PubMed ID: 31726100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How receptor tyrosine kinase-like orphan receptor 1 meets its partners in chronic lymphocytic leukemia.
    Mouawad N; Ruggeri E; Capasso G; Martinello L; Visentin A; Frezzato F; Trentin L
    Hematol Oncol; 2024 Mar; 42(2):e3250. PubMed ID: 38949887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of targeting ROR1 in primates with chimeric antigen receptor-modified T cells.
    Berger C; Sommermeyer D; Hudecek M; Berger M; Balakrishnan A; Paszkiewicz PJ; Kosasih PL; Rader C; Riddell SR
    Cancer Immunol Res; 2015 Feb; 3(2):206-16. PubMed ID: 25355068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A fully chimeric IgG antibody for ROR1 suppresses ovarian cancer growth in vitro and in vivo.
    Yin Z; Mao Y; Zhang N; Su Y; Zhu J; Tong H; Zhang H
    Biomed Pharmacother; 2019 Nov; 119():109420. PubMed ID: 31536932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody-drug conjugate T-DM1 treatment for HER2+ breast cancer induces ROR1 and confers resistance through activation of Hippo transcriptional coactivator YAP1.
    Islam SS; Uddin M; Noman ASM; Akter H; Dity NJ; Basiruzzman M; Uddin F; Ahsan J; Annoor S; Alaiya AA; Al-Alwan M; Yeger H; Farhat WA
    EBioMedicine; 2019 May; 43():211-224. PubMed ID: 31085100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The receptor tyrosine kinase ROR1--an oncofetal antigen for targeted cancer therapy.
    Hojjat-Farsangi M; Moshfegh A; Daneshmanesh AH; Khan AS; Mikaelsson E; Osterborg A; Mellstedt H
    Semin Cancer Biol; 2014 Dec; 29():21-31. PubMed ID: 25068995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of receptor tyrosine kinase-like orphan receptor 1 in preeclampsia placenta inhibits human trophoblast cell proliferation, migration, and invasion by PI3K/AKT/mTOR pathway accommodation.
    Chen J; Yue C; Xu J; Zhan Y; Zhao H; Li Y; Ye Y
    Placenta; 2019 Jul; 82():17-24. PubMed ID: 31174622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ROR1 and ROR2 expression in pancreatic cancer.
    Liu D; Sharbeen G; Phillips P; ; Ford CE
    BMC Cancer; 2021 Nov; 21(1):1199. PubMed ID: 34763666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth.
    Zhang S; Chen L; Cui B; Chuang HY; Yu J; Wang-Rodriguez J; Tang L; Chen G; Basak GW; Kipps TJ
    PLoS One; 2012; 7(3):e31127. PubMed ID: 22403610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twist promotes tumor metastasis in basal-like breast cancer by transcriptionally upregulating ROR1.
    Cao J; Wang X; Dai T; Wu Y; Zhang M; Cao R; Zhang R; Wang G; Jiang R; Zhou BP; Shi J; Kang T
    Theranostics; 2018; 8(10):2739-2751. PubMed ID: 29774072
    [No Abstract]   [Full Text] [Related]  

  • 36. miR-379-5p inhibits proliferation and invasion of the endometrial cancer cells by inhibiting expression of ROR1.
    Liang M; Chen H; Min J
    Acta Biochim Pol; 2021 Jun; 68(4):659-665. PubMed ID: 34115460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The signaling pathways activated by ROR1 in cancer.
    Quezada MJ; Lopez-Bergami P
    Cell Signal; 2023 Apr; 104():110588. PubMed ID: 36621728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do patients with oral squamous cell carcinoma express receptor tyrosine kinase-like orphan receptor 1? Results of an observational study.
    Nema S; Kallianpur S; Kumar A; Nema R; Vishwakarma S; Nema SK
    J Oral Maxillofac Pathol; 2021; 25(1):105-109. PubMed ID: 34349419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stat3 activates the receptor tyrosine kinase like orphan receptor-1 gene in chronic lymphocytic leukemia cells.
    Li P; Harris D; Liu Z; Liu J; Keating M; Estrov Z
    PLoS One; 2010 Jul; 5(7):e11859. PubMed ID: 20686606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
    Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C
    Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.